Target antigen screening and development of a multi-component subunit vaccine against Mycoplasma synoviae in chickens
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1458865 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Xiaomei Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, China. Hauptthemen laut MEDLINE: Mycoplasma synoviae, Vaccines, Subunit, Chickens, Poultry Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Mycoplasma synoviae (MS) is a globally important avian pathogen causing infectious synovitis and respiratory diseases in poultry, leading to significant economic losses. Despite advances in vaccine development, a commercially viable subunit vaccine against MS remains elusive.
Methods
We sequenced whole genomes of six clinical MS strains isolated from different Chinese provinces. Common genes were analyzed using Biopython software, identifying those with high copy numbers in virulent strains and shared among all strains. Vaxign2 and IEDB Antibody Epitope Prediction were used to analyze protein properties. We assessed immune protective effects of candidate proteins and developed a multivalent subunit vaccine.
Results
Ten candidate vaccine proteins were initially selected. A multivalent subunit vaccine composed of MSPB, Ppht, Cfba, and EF-G displayed the best protective effect. The optimal immunization dosage was 20μg, with each protein accounting for 25%. The immune production period was determined to be 28 days post-first immunization, lasting 180 days. The immune protection rate against highly virulent strains reached 90%∼100%.
Discussion
This study provides a new approach for screening vaccine antigens and develops an effective candidate vaccine for MS prevention. The multivalent subunit vaccine shows promising results in protecting against MS infections, potentially offering a solution to reduce economic losses in the poultry industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, China.
- College of Animal Medicine, Huazhong Agricultural University, Wuhan, China.
- The Cooperative Innovation Center for Sustainable Pig Production, Wuhan, China.
- Research Institute of Wuhan Keqian biology Co., Ltd, Wuhan, China.
- Hubei Province Animal Disease Comprehensive Prevention and Control Industry Technology Innovation Alliance, Wuhan, China.
- Hubei Jiangxia Laboratory, Wuhan, China.
Zitieren
APA
Sun, X., Deng, M., Cheng, C., Zhao, Y., Liu, Z., Yang, Y., Xu, Q., Yao, R., Hu, M., Jin, M., & Kang, C. (2024). Target antigen screening and development of a multi-component subunit vaccine against Mycoplasma synoviae in chickens. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1458865
Vancouver
Sun X, Deng M, Cheng C, Zhao Y, Liu Z, Yang Y, et al. Target antigen screening and development of a multi-component subunit vaccine against Mycoplasma synoviae in chickens. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1458865
BibTeX
@article{Sun2024,
author = {Sun, Xiaomei and Deng, Mingyong and Cheng, Chuxing and Zhao, Ya and Liu, Zuqing and Yang, Yu and Xu, Qiaoxia and Yao, Rong and Hu, Min and Jin, Meilin and Kang, Chao},
title = {Target antigen screening and development of a multi-component subunit vaccine against Mycoplasma synoviae in chickens},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1458865}
}
EUVIMED